Inventor · disambiguated record
Stefan Anker
Also filed as: ANKER STEFAN · ANKER STEFAN DIETMAR
18 granted patents·7 pending applications·42 citations·filing 1999–2024
91Inventor score
Files withACTIMED THERAPEUTICS LTD10ANKER STEFAN3BERGMANN ANDREAS2IMP INNOVATIONS LTD2PAR PHARMACEUTICALS INC2
Top patents by PatentIndex Score
25 records- 0188US8252544B2Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patientsBERGMANN ANDREAS·Filed 2008·Granted Aug 28, 2012·13 cites·16 claims
- 0283US12303474B2S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosisACTIMED THERAPEUTICS LTD·Filed 2024·Granted May 20, 2025·0 cites·16 claims
- 0380US10828270B2Oxprenolol compositions for treating cancerACTIMED THERAPEUTICS LTD·Filed 2018·Granted Nov 10, 2020·1 cites·16 claims
- 0477US8647830B2Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac diseaseBERGMANN ANDREAS·Filed 2008·Granted Feb 11, 2014·5 cites·19 claims
- 0573US11938102B2S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosisACTIMED THERAPEUTICS LTD·Filed 2021·Granted Mar 26, 2024·0 cites·13 claims
- 0669US10398658B2Oxprenolol compositions for treating cancerACTIMED THERAPEUTICS LTD·Filed 2014·Granted Sep 3, 2019·1 cites·10 claims
- 0768US11433036B2Oxprenolol compositions for treating cancerACTIMED THERAPEUTICS LTD·Filed 2020·Granted Sep 6, 2022·0 cites·20 claims
- 0868US10016397B2Selective AT2 receptor agonists for use in treatment of cachexiaUNIV BERLIN CHARITE·Filed 2014·Granted Jul 10, 2018·2 cites·20 claims
- 0967US8835485B2Prevention and treatment of sarcopeniaSPRINGER JOCHEN·Filed 2010·Granted Sep 16, 2014·1 cites·8 claims
- 1067US2021346320A1S-enantiomerically enriched compositions of beta blockers for treating muscle weaknessACTIMED THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1166US11382876B2S-enantiomerically enriched compositions of beta blockers for treating muscle weaknessACTIMED THERAPEUTICS LTD·Filed 2020·Granted Jul 12, 2022·0 cites·15 claims
- 1266US11007158B2S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosisACTIMED THERAPEUTICS LTD·Filed 2019·Granted May 18, 2021·0 cites·14 claims
- 1361US10449166B2S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosisACTIMED THERAPEUTICS LTD·Filed 2014·Granted Oct 22, 2019·0 cites·15 claims
- 1461US7417038B1Methods of treating cachexiaIMP INNOVATIONS LTD·Filed 1999·Granted Aug 26, 2008·19 cites·10 claims
- 1557US11096908B2S-enantiomerically enriched compositions of beta blockers for treating muscle weaknessACTIMED THERAPEUTICS LTD·Filed 2017·Granted Aug 24, 2021·0 cites·16 claims
- 1657US7829596B2Methods of treatmentIMP INNOVATIONS LTD·Filed 2008·Granted Nov 9, 2010·0 cites·5 claims
- 1755US8383612B2Use of megestrol acetate for improving heart function and the treatment of heart insufficiencyPAR PHARMACEUTICALS INC·Filed 2005·Granted Feb 26, 2013·0 cites·19 claims
- 1852US2009197851A1Therapy and use of compounds in therapyMAX DELBRUECK CENTRUM·Filed 2008·Application pending·0 cites
- 1952US2007197485A1Therapy and Use of Compounds in TherapyMAX DELBRUECK CT FUR MOLEKULAR·Filed 2007·Application pending·0 cites
- 2052US2013143848A1Use of megestrol acetate for improving heart function and the treatment of heart insufficiencyPAR PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2148US2016101117A1Use of Megestrol Acetate for Improving Heart Function and the Treatment of Heart InsufficiencyPAR PHARMACEUTICAL INC·Filed 2015·Application pending·0 cites
- 2245US8655445B2Method for enhancing the performance and general condition of a subjectANKER STEFAN·Filed 2013·Granted Feb 18, 2014·0 cites·28 claims
- 2344US8483824B2Method for enhancing the performance and general condition of a subjectANKER STEFAN·Filed 2006·Granted Jul 9, 2013·0 cites·30 claims
- 2437US2008269179A1Use of Megestrol Acetate for the Treatment of Obstructive Pulmonary DiseasesANKER STEFAN·Filed 2006·Application pending·0 cites
- 2533US2014194484A1Method of Treating Cachexia and SarcopeniaCOATS ANDREW·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →